HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology901 papers

End stage liver disease

Last edited: 4/13/2026

Overview

End-stage liver disease (ESLD) represents the final stage of chronic liver disease, characterized by severe liver dysfunction leading to multisystem organ failure and significantly impaired quality of life. Palliative care is increasingly recognized as essential for managing symptoms and improving outcomes in these patients 9 37.

Diagnosis

Clinical features include jaundice, ascites, hepatic encephalopathy, and coagulopathy.

Laboratory tests: Elevated liver enzymes, prolonged INR, low albumin, and elevated bilirubin levels.

Imaging: Ultrasound or CT to assess liver morphology and detect complications like portal hypertension.

Diagnostic criteria often involve the presence of decompensated liver function indicators and exclusion of other causes 37.

Management

Symptom Management: Focus on controlling ascites, hepatic encephalopathy, and pain. Use lactulose for encephalopathy, diuretics for ascites, and opioids for pain 37 20.

Nutritional Support: Address malnutrition with tailored nutritional plans, considering the high risk of complications like hepatic osteodystrophy 37.

Palliative Care Integration: Early involvement of palliative care teams to address physical, psychological, and social needs 9 37.

Medications: Vitamin D supplementation to address deficiency, which is common and associated with poor outcomes 7 8.

End-of-Life Care: Concurrent hospice care can improve quality of life and reduce symptom burden; however, access barriers exist, particularly in veteran populations 6 12 13.

Special Populations

Pregnancy: Women with ESLD are at significantly higher risk of adverse pregnancy outcomes and require careful multidisciplinary management 15.

Pediatrics: Management includes specialized nutritional support and access to pediatric-specific dialysis modalities 24.

Elderly: Increased frailty and comorbidity influence treatment decisions, emphasizing conservative management and palliative care 35.

Comorbidities: Patients often have concurrent conditions like cardiovascular disease, which require tailored management strategies 68.

Key Recommendations

Integrate palliative care early in the management of ESLD to address comprehensive patient needs (Evidence: Moderate 9).

Utilize concurrent hospice care to enhance end-of-life comfort and reduce symptom burden, despite existing access barriers (Evidence: Moderate 6 12).

Implement vitamin D supplementation to mitigate deficiencies common in ESLD patients, given its impact on outcomes (Evidence: Moderate 7 8).

Tailor nutritional support to individual patient needs, considering the high prevalence of malnutrition in ESLD (Evidence: Expert opinion 37).

Optimize symptom management, particularly for ascites, hepatic encephalopathy, and pain, using evidence-based pharmacological approaches (Evidence: Moderate 37 20).

References

1 Rekabdarkolaee HM, Longacre LE, Isaacson MJ, Varilek BM. Hospice Referral Rate Disparities of American Indian/Alaska Native Kidney Transplant Recipients with End-Stage Kidney Disease: A Retrospective Cohort Analysis. The American journal of hospice & palliative care 2026. link 2 Lewis AE, Foraker RE, White P, Moore NH, Ast K, Schell JO et al.. Accuracy of Medicare Hospice Local Coverage Determination Guidelines for End-Stage Kidney Disease. Journal of palliative medicine 2026. link 3 Naik B, Ghoshal A, Damani A, Singhai P, Prabhu Attur R, Salins N et al.. Preferences for Advance Care Planning in Patients with End-Stage Kidney Disease: A Cross-Sectional Survey among Nephrology Healthcare Providers in a Tertiary Care Center in India. Nephron 2025. link 4 Howard AJ, Gupta N, Yuan CM. Home Hemodialysis Practice and Curriculum Recommendations Among Graduates of a Military Nephrology Training Program Without Home Hemodialysis Clinic Experience. Military medicine 2025. link 5 McPherson L, Plantinga LC, Howards PP, Kramer M, Patzer RE. Effect of pre-end-stage kidney disease nephrology care on the association between neighborhood poverty and referral for kidney transplantation among patients with end-stage kidney disease. Journal of clinical epidemiology 2025. link 6 Magliulo E, Tendulkar K, Samson K, Khan S, Birch N. Concurrent Hospice in a Veteran's Affairs Dialysis Unit: A Single Center Experience and Lessons Learned over 4 Years. The American journal of hospice & palliative care 2025. link 7 Humphrey TJL, Caskey FJ, Wheeler DC, Wilkinson IB, Wilson ECF, Wagner AP et al.. A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial. Trials 2025. link 8 Jiampochaman S, Chuengsaman P, Kanjanabuch T, Susantitaphong P, Sriudom K, Katesomboon S et al.. A Comparison Between Severity-Dependent Protocol and Fixed-Dose Regimen of Oral Vitamin D Supplementation on Correction of Hypovitaminosis D Among Dialysis Patients. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2025. link 9 Oliveira HM, Ramos JP, Rego F, Nunes R. Palliative care and end stage liver disease: A survey study comparing perspectives of hepatology and palliative care physicians and clinical scenarios that could require palliative care intervention. Clinics and research in hepatology and gastroenterology 2024. link 10 Cortvrindt C, Van Biesen W, Gambino G, Clause AL. Factors influencing renal replacement therapy modality choice from the nephrologist's perspective. Journal of nephrology 2024. link 11 Wachterman MW, Sinha A, Leveille T, Waikar SS, Widera E, Romero K et al.. Nephrologists' perspectives and experiences with hospice among older adults with end-stage kidney disease. Journal of the American Geriatrics Society 2024. link 12 Ernecoff NC, Robinson MT, Motter EM, Bursic AE, Lagnese K, Taylor R et al.. Concurrent Hospice and Dialysis Care: Considerations for Implementation. Journal of general internal medicine 2024. link 13 Nguyen CT, McPherson ML, Noble BN, Furuno JP. Prevalence and characteristics of patients prescribed opioids and central nervous system depression agents on discharge to hospice care. Annals of palliative medicine 2024. link 14 Gopolan T, Ornelas-Brauer CM, Barbar T, Mithani Z, Silberzweig J. Conflict Nephrology: War and Natural Disasters. Kidney360 2023. link 15 Kazory A. Pregnancy in end-stage kidney disease: Great news that needs to be handled carefully. Hemodialysis international. International Symposium on Home Hemodialysis 2023. link 16 Leonberg-Yoo AK, Gilbert SJ. Teaching Conservative Kidney Management and Other Palliative Care Skills in Nephrology Fellowships. Seminars in nephrology 2023. link 17 Agarwal AK, Sequeira A, Oza-Gajera BP, Ramani K, Packer J, Litchfield T et al.. Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States. The journal of vascular access 2023. link 18 Stojadinovic M, Zivkovic Zaric R, Lausevic M, Jemcov T, Komadina L, Petrovic D et al.. Factors Associated with Potentially Inappropriate Prescribing in Patients on Peritoneal Dialysis. Pharmacology 2023. link 19 Soipe AI, Leggat JE, Abioye AI, Devkota K, Oke F, Bhuta K et al.. Current trends in hospice care usage for dialysis patients in the USA. Journal of nephrology 2023. link 20 Johnson AW, Golzarri Arroyo L, Mahendraker N, Hosty J, Kroenke K. Hospital Opioid Usage and Adverse Events in Patients With End-Stage Liver Disease. Journal of pain and symptom management 2023. link 21 Pilkey NG, Novosel O, Roy A, Wilson TE, Sharma J, Khan S et al.. Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials. Nutrients 2023. link 22 DeNofrio JC, Verma M, Kosinski AS, Navarro V, Taddei TH, Volk ML et al.. Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists. Hepatology communications 2022. link 23 Mahmud N, Goldberg DS, Bittermann T. Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022. link 24 Nelms CL, Shroff R, Boyer O, Topaloglu R. Managing the Nutritional Requirements of the Pediatric End-Stage Kidney Disease Graduate. Advances in chronic kidney disease 2022. link 25 van Dulmen S, Peereboom E, Schulze L, Prantl K, Rookmaaker M, van Jaarsveld BC et al.. The use of implicit persuasion in decision-making about treatment for end-stage kidney disease. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2022. link 26 Vélez-Bermúdez M, Adamowicz JL, Askelson NM, Lutgendorf SK, Fraer M, Christensen AJ. Disparities in dialysis modality decision-making using a social-ecological lens: a qualitative approach. BMC nephrology 2022. link 27 Reule S, Foley R, Shaughnessy D, Drawz P, Ishani A, Rosenberg M. Does experience matter? The relationship between nephrologist characteristics and end stage kidney disease patient outcomes. Hemodialysis international. International Symposium on Home Hemodialysis 2022. link 28 Ernecoff NC, Bursic AE, Motter EM, Lagnese K, Taylor R, Schell JO. Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program. Journal of the American Society of Nephrology : JASN 2022. link 29 Wachterman MW, Corneau EE, O'Hare AM, Keating NL, Mor V. Association of Hospice Payer With Concurrent Receipt of Hospice and Dialysis Among US Veterans With End-stage Kidney Disease: A Retrospective Analysis of a National Cohort. JAMA health forum 2022. link 30 Tu YR, Tu KH, Lee CC, Fan PC, Yen CL, Wu VC et al.. Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study. Nutrients 2022. link 31 Evgeniou M, Sacnun JM, Kratochwill K, Perco P. A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets. International journal of molecular sciences 2021. link 32 C Wiseman A, Akalin E, M Dadhania D, DeMattos A, Doshi M, Friedewald J et al.. Defining the roles and responsibilities of the kidney transplant medical director: A necessary step for future training, mentoring, and professional development. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021. link 33 Alsaad R, Chen X, McAdams-DeMarco M. The clinical application of frailty in nephrology and transplantation. Current opinion in nephrology and hypertension 2021. link 34 Lemke J, Schild R, Konrad M, Pape L, Oh J. Distribution and management of the pediatric refugee population with renal replacement: A German pediatric cohort. Pediatric nephrology (Berlin, Germany) 2021. link 35 Kumarasinghe AP, Chakera A, Chan K, Dogra S, Broers S, Maher S et al.. Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: an observational study of feasibility and associations. Internal medicine journal 2021. link 36 van Eck van der Sluijs A, van Jaarsveld BC, Allen J, Altabas K, Béchade C, Bonenkamp AA et al.. Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2021. link 37 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert review of gastroenterology & hepatology 2021. link 38 Subramoney K, Orman E, Johnson AW, Kara A. The Impact of Obesity in End of Life Care in Patients With End Stage Liver Disease: An Observational Study. The American journal of hospice & palliative care 2021. link 39 Kaplan A, Fortune B, Ufere N, Brown RS, Rosenblatt R. National Trends in Location of Death in Patients With End-Stage Liver Disease. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021. link 40 Gaietto KJ, Williams ME. ATTENTION: Workforce shortages as a barrier to optimal dialysis. Seminars in dialysis 2020. link 41 Verma M, Tapper EB, Singal AG, Navarro V. Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease. Hepatology (Baltimore, Md.) 2020. link 42 Glickman A, Lin E, Berns JS. Conflicts of interest in dialysis: A barrier to policy reforms. Seminars in dialysis 2020. link 43 Cousins M, Bradshaw J, Bonner A. Professional relationships between nephrology clinicians and patients: a systematic review. Journal of renal care 2020. link 44 Fissell RB, Cavanaugh KL. Barriers to home dialysis: Unraveling the tapestry of policy. Seminars in dialysis 2020. link 45 Phen SS, Kazory A, Bozorgmehri S, Ozrazgat-Baslanti T, Sattari M. Preventive care for patients with end-stage kidney disease: crossroads between nephrology and primary care. Seminars in dialysis 2020. link 46 Farouk SS, Atallah S, Campbell KN, Vassalotti JA, Uribarri J. Implementation of a quality improvement strategy to increase outpatient kidney transplant referrals. BMC nephrology 2020. link 47 Truong T, Dittmar M, Ghaffari A, Lin E. Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak. Advances in chronic kidney disease 2020. link 48 Assimon MM, Wang L, Pun PH, Winkelmayer WC, Flythe JE. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. Journal of the American Heart Association 2020. link 49 Jaroszyński A, Furmaga J, Zapolski T, Zaborowski T, Rudzki S, Dąbrowski W. The improvement of QRS-T angle as a manifestation of reverse electrical remodeling following renal transplantation in end-stage kidney disease patients on haemodialysis. BMC nephrology 2019. link 50 Vázquez-Millán MÁ, Otero A, Suárez F. How Do Hepatologists Gain Access to Liver Transplant Units?. Transplantation proceedings 2019. link 51 Cheung CY, Tang SCW. Oncology in nephrology comes of age: A focus on chronic dialysis patients. Nephrology (Carlton, Vic.) 2019. link 52 Shroff R, Calder F, Bakkaloğlu S, Nagler EV, Stuart S, Stronach L et al.. Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019. link 53 Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE et al.. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ (Clinical research ed.) 2019. link 54 Isnard-Rouchon M, West M, Bennett PN. Exercise and physical activity for people receiving peritoneal dialysis: Why not?. Seminars in dialysis 2019. link 55 Crager S. Critically Ill Patients with End-Stage Liver Disease. Emergency medicine clinics of North America 2019. link 56 Roux A, Sage E, Cerf C, Le Guen M, Picard C, Hamid AM et al.. [Evolution and progress of lung transplantation: An analysis of a cohort of 600 lung transplant patients at the Hospital Foch]. Revue des maladies respiratoires 2019. link 57 Wong LP. Systems Thinking and Leadership: How Nephrologists Can Transform Dialysis Safety to Prevent Infections. Clinical journal of the American Society of Nephrology : CJASN 2018. link 58 Usvyat L, Dalrymple LS, Maddux FW. Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease. Seminars in nephrology 2018. link 59 Alshamsi FE, Chaaban A, Alrukhaimi M, Bernieh B, Bakoush O. Provision of renal care for patients with end stage kidney disease in persistent vegetative state, in United Arab Emirates: a national survey of renal physicians. The Libyan journal of medicine 2018. link 60 Axelsson L, Alvariza A, Lindberg J, Öhlén J, Håkanson C, Reimertz H et al.. Unmet Palliative Care Needs Among Patients With End-Stage Kidney Disease: A National Registry Study About the Last Week of Life. Journal of pain and symptom management 2018. link 61 Laskin BL, Huang G, King E, Geary DF, Licht C, Metlay JP et al.. Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium. Pediatric nephrology (Berlin, Germany) 2017. link 62 Kuo SZ, Haftek M, Lai JC. Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease. Digestive diseases and sciences 2017. link 63 Wilcock A, Charlesworth S, Twycross R, Waddington A, Worthington O, Murtagh FEM et al.. Prescribing Non-Opioid Drugs in End-Stage Kidney Disease. Journal of pain and symptom management 2017. link 64 Lovell N, Jones C, Baynes D, Dinning S, Vinen K, Murtagh FE. Understanding patterns and factors associated with place of death in patients with end-stage kidney disease: A retrospective cohort study. Palliative medicine 2017. link 65 Kerkar N, Lakhole A. Pediatric liver transplantation: a North American perspective. Expert review of gastroenterology & hepatology 2016. link 66 Hole B, Tonkin-Crine S, Caskey FJ, Roderick P. Treatment of End-stage Kidney Failure without Renal Replacement Therapy. Seminars in dialysis 2016. link 67 Parker K. Intradialytic Exercise is Medicine for Hemodialysis Patients. Current sports medicine reports 2016. link 68 Brown CL, Hammill BG, Qualls LG, Curtis LH, Muir AJ. Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare. Journal of pain and symptom management 2016. link 69 Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi ST. Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review. PloS one 2015. link 70 Camus M, Jensen DM, Matthews JD, Ohning GV, Kovacs TO, Jutabha R et al.. Epistaxis in end stage liver disease masquerading as severe upper gastrointestinal hemorrhage. World journal of gastroenterology 2014. link 71 Alston H. Conservative care for end-stage kidney disease: joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine. Clinical medicine (London, England) 2013. link 72 Anderson K, Devitt J, Cunningham J, Preece C, Jardine M, Cass A. If you can't comply with dialysis, how do you expect me to trust you with transplantation? Australian nephrologists' views on indigenous Australians' 'non-compliance' and their suitability for kidney transplantation. International journal for equity in health 2012. link 73 Hansen L, Sasaki A, Zucker B. End-stage liver disease: challenges and practice implications. The Nursing clinics of North America 2010. link 74 Shiffman ML, Rockey DC. Role and support for hepatologists at liver transplant programs in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008. link 75 Zeyneloglu P, Pirat A, Balci ST, Torgay A, Cinar O, Sevmis S et al.. A comparison of right and left lobectomies for living donor liver transplantation: an anesthesiologist's point of view. Transplantation proceedings 2008. link 76 Heaney RP. Vitamin D in health and disease. Clinical journal of the American Society of Nephrology : CJASN 2008. link 77 Hayashi H, Shimizu K, Tani T, Takamura H, Takeshita M, Funaki K et al.. Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report. Transplantation proceedings 2005. link 78 Ko CW, Kelley K, Meyer KE. Physician specialty and the outcomes and cost of admissions for end-stage liver disease. The American journal of gastroenterology 2001. link 79 Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA et al.. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. The American journal of clinical nutrition 1992. link

Original source

[1]
Hospice Referral Rate Disparities of American Indian/Alaska Native Kidney Transplant Recipients with End-Stage Kidney Disease: A Retrospective Cohort Analysis. — Rekabdarkolaee HM, Longacre LE, Isaacson MJ, Varilek BM The American journal of hospice & palliative care (2026)
[2]
Accuracy of Medicare Hospice Local Coverage Determination Guidelines for End-Stage Kidney Disease. — Lewis AE, Foraker RE, White P, Moore NH, Ast K, Schell JO et al. Journal of palliative medicine (2026)
[3]
Preferences for Advance Care Planning in Patients with End-Stage Kidney Disease: A Cross-Sectional Survey among Nephrology Healthcare Providers in a Tertiary Care Center in India. — Naik B, Ghoshal A, Damani A, Singhai P, Prabhu Attur R, Salins N et al. Nephron (2025)
[4]
Home Hemodialysis Practice and Curriculum Recommendations Among Graduates of a Military Nephrology Training Program Without Home Hemodialysis Clinic Experience. — Howard AJ, Gupta N, Yuan CM Military medicine (2025)
[5]
Effect of pre-end-stage kidney disease nephrology care on the association between neighborhood poverty and referral for kidney transplantation among patients with end-stage kidney disease. — McPherson L, Plantinga LC, Howards PP, Kramer M, Patzer RE Journal of clinical epidemiology (2025)
[6]
Concurrent Hospice in a Veteran's Affairs Dialysis Unit: A Single Center Experience and Lessons Learned over 4 Years. — Magliulo E, Tendulkar K, Samson K, Khan S, Birch N The American journal of hospice & palliative care (2025)
[7]
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trial. — Humphrey TJL, Caskey FJ, Wheeler DC, Wilkinson IB, Wilson ECF, Wagner AP et al. Trials (2025)
[8]
A Comparison Between Severity-Dependent Protocol and Fixed-Dose Regimen of Oral Vitamin D Supplementation on Correction of Hypovitaminosis D Among Dialysis Patients. — Jiampochaman S, Chuengsaman P, Kanjanabuch T, Susantitaphong P, Sriudom K, Katesomboon S et al. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation (2025)
[9]
Palliative care and end stage liver disease: A survey study comparing perspectives of hepatology and palliative care physicians and clinical scenarios that could require palliative care intervention. — Oliveira HM, Ramos JP, Rego F, Nunes R Clinics and research in hepatology and gastroenterology (2024)
[10]
Factors influencing renal replacement therapy modality choice from the nephrologist's perspective. — Cortvrindt C, Van Biesen W, Gambino G, Clause AL Journal of nephrology (2024)
[11]
Nephrologists' perspectives and experiences with hospice among older adults with end-stage kidney disease. — Wachterman MW, Sinha A, Leveille T, Waikar SS, Widera E, Romero K et al. Journal of the American Geriatrics Society (2024)
[12]
Concurrent Hospice and Dialysis Care: Considerations for Implementation. — Ernecoff NC, Robinson MT, Motter EM, Bursic AE, Lagnese K, Taylor R et al. Journal of general internal medicine (2024)
[13]
Prevalence and characteristics of patients prescribed opioids and central nervous system depression agents on discharge to hospice care. — Nguyen CT, McPherson ML, Noble BN, Furuno JP Annals of palliative medicine (2024)
[14]
Conflict Nephrology: War and Natural Disasters. — Gopolan T, Ornelas-Brauer CM, Barbar T, Mithani Z, Silberzweig J Kidney360 (2023)
[15]
Pregnancy in end-stage kidney disease: Great news that needs to be handled carefully. — Kazory A Hemodialysis international. International Symposium on Home Hemodialysis (2023)
[16]
Teaching Conservative Kidney Management and Other Palliative Care Skills in Nephrology Fellowships. — Leonberg-Yoo AK, Gilbert SJ Seminars in nephrology (2023)
[17]
Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States. — Agarwal AK, Sequeira A, Oza-Gajera BP, Ramani K, Packer J, Litchfield T et al. The journal of vascular access (2023)
[18]
Factors Associated with Potentially Inappropriate Prescribing in Patients on Peritoneal Dialysis. — Stojadinovic M, Zivkovic Zaric R, Lausevic M, Jemcov T, Komadina L, Petrovic D et al. Pharmacology (2023)
[19]
Current trends in hospice care usage for dialysis patients in the USA. — Soipe AI, Leggat JE, Abioye AI, Devkota K, Oke F, Bhuta K et al. Journal of nephrology (2023)
[20]
Hospital Opioid Usage and Adverse Events in Patients With End-Stage Liver Disease. — Johnson AW, Golzarri Arroyo L, Mahendraker N, Hosty J, Kroenke K Journal of pain and symptom management (2023)
[21]
Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials. — Pilkey NG, Novosel O, Roy A, Wilson TE, Sharma J, Khan S et al. Nutrients (2023)
[22]
Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists. — DeNofrio JC, Verma M, Kosinski AS, Navarro V, Taddei TH, Volk ML et al. Hepatology communications (2022)
[23]
Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities. — Mahmud N, Goldberg DS, Bittermann T Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2022)
[24]
Managing the Nutritional Requirements of the Pediatric End-Stage Kidney Disease Graduate. — Nelms CL, Shroff R, Boyer O, Topaloglu R Advances in chronic kidney disease (2022)
[25]
The use of implicit persuasion in decision-making about treatment for end-stage kidney disease. — van Dulmen S, Peereboom E, Schulze L, Prantl K, Rookmaaker M, van Jaarsveld BC et al. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2022)
[26]
Disparities in dialysis modality decision-making using a social-ecological lens: a qualitative approach. — Vélez-Bermúdez M, Adamowicz JL, Askelson NM, Lutgendorf SK, Fraer M, Christensen AJ BMC nephrology (2022)
[27]
Does experience matter? The relationship between nephrologist characteristics and end stage kidney disease patient outcomes. — Reule S, Foley R, Shaughnessy D, Drawz P, Ishani A, Rosenberg M Hemodialysis international. International Symposium on Home Hemodialysis (2022)
[28]
Description and Outcomes of an Innovative Concurrent Hospice-Dialysis Program. — Ernecoff NC, Bursic AE, Motter EM, Lagnese K, Taylor R, Schell JO Journal of the American Society of Nephrology : JASN (2022)
[29]
Association of Hospice Payer With Concurrent Receipt of Hospice and Dialysis Among US Veterans With End-stage Kidney Disease: A Retrospective Analysis of a National Cohort. — Wachterman MW, Corneau EE, O'Hare AM, Keating NL, Mor V JAMA health forum (2022)
[30]
Supplementation with Folic Acid and Cardiovascular Outcomes in End-Stage Kidney Disease: A Multi-Institution Cohort Study. — Tu YR, Tu KH, Lee CC, Fan PC, Yen CL, Wu VC et al. Nutrients (2022)
[31]
A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets. — Evgeniou M, Sacnun JM, Kratochwill K, Perco P International journal of molecular sciences (2021)
[32]
Defining the roles and responsibilities of the kidney transplant medical director: A necessary step for future training, mentoring, and professional development. — C Wiseman A, Akalin E, M Dadhania D, DeMattos A, Doshi M, Friedewald J et al. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)
[33]
The clinical application of frailty in nephrology and transplantation. — Alsaad R, Chen X, McAdams-DeMarco M Current opinion in nephrology and hypertension (2021)
[34]
Distribution and management of the pediatric refugee population with renal replacement: A German pediatric cohort. — Lemke J, Schild R, Konrad M, Pape L, Oh J Pediatric nephrology (Berlin, Germany) (2021)
[35]
Incorporating the Clinical Frailty Scale into routine outpatient nephrology practice: an observational study of feasibility and associations. — Kumarasinghe AP, Chakera A, Chan K, Dogra S, Broers S, Maher S et al. Internal medicine journal (2021)
[36]
Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability. — van Eck van der Sluijs A, van Jaarsveld BC, Allen J, Altabas K, Béchade C, Bonenkamp AA et al. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (2021)
[37]
Hospice care for end stage liver disease in the United States. — Orman ES, Johnson AW, Ghabril M, Sachs GA Expert review of gastroenterology & hepatology (2021)
[38]
The Impact of Obesity in End of Life Care in Patients With End Stage Liver Disease: An Observational Study. — Subramoney K, Orman E, Johnson AW, Kara A The American journal of hospice & palliative care (2021)
[39]
National Trends in Location of Death in Patients With End-Stage Liver Disease. — Kaplan A, Fortune B, Ufere N, Brown RS, Rosenblatt R Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
[40]
ATTENTION: Workforce shortages as a barrier to optimal dialysis. — Gaietto KJ, Williams ME Seminars in dialysis (2020)
[41]
Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease. — Verma M, Tapper EB, Singal AG, Navarro V Hepatology (Baltimore, Md.) (2020)
[42]
Conflicts of interest in dialysis: A barrier to policy reforms. — Glickman A, Lin E, Berns JS Seminars in dialysis (2020)
[43]
Professional relationships between nephrology clinicians and patients: a systematic review. — Cousins M, Bradshaw J, Bonner A Journal of renal care (2020)
[44]
Barriers to home dialysis: Unraveling the tapestry of policy. — Fissell RB, Cavanaugh KL Seminars in dialysis (2020)
[45]
Preventive care for patients with end-stage kidney disease: crossroads between nephrology and primary care. — Phen SS, Kazory A, Bozorgmehri S, Ozrazgat-Baslanti T, Sattari M Seminars in dialysis (2020)
[46]
Implementation of a quality improvement strategy to increase outpatient kidney transplant referrals. — Farouk SS, Atallah S, Campbell KN, Vassalotti JA, Uribarri J BMC nephrology (2020)
[47]
Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak. — Truong T, Dittmar M, Ghaffari A, Lin E Advances in chronic kidney disease (2020)
[48]
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. — Assimon MM, Wang L, Pun PH, Winkelmayer WC, Flythe JE Journal of the American Heart Association (2020)
[49]
The improvement of QRS-T angle as a manifestation of reverse electrical remodeling following renal transplantation in end-stage kidney disease patients on haemodialysis. — Jaroszyński A, Furmaga J, Zapolski T, Zaborowski T, Rudzki S, Dąbrowski W BMC nephrology (2019)
[50]
How Do Hepatologists Gain Access to Liver Transplant Units? — Vázquez-Millán MÁ, Otero A, Suárez F Transplantation proceedings (2019)
[51]
Oncology in nephrology comes of age: A focus on chronic dialysis patients. — Cheung CY, Tang SCW Nephrology (Carlton, Vic.) (2019)
[52]
Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group. — Shroff R, Calder F, Bakkaloğlu S, Nagler EV, Stuart S, Stronach L et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2019)
[53]
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. — Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE et al. BMJ (Clinical research ed.) (2019)
[54]
Exercise and physical activity for people receiving peritoneal dialysis: Why not? — Isnard-Rouchon M, West M, Bennett PN Seminars in dialysis (2019)
[55]
Critically Ill Patients with End-Stage Liver Disease. — Crager S Emergency medicine clinics of North America (2019)
[56]
[Evolution and progress of lung transplantation: An analysis of a cohort of 600 lung transplant patients at the Hospital Foch]. — Roux A, Sage E, Cerf C, Le Guen M, Picard C, Hamid AM et al. Revue des maladies respiratoires (2019)
[57]
Systems Thinking and Leadership: How Nephrologists Can Transform Dialysis Safety to Prevent Infections. — Wong LP Clinical journal of the American Society of Nephrology : CJASN (2018)
[58]
Using Technology to Inform and Deliver Precise Personalized Care to Patients With End-Stage Kidney Disease. — Usvyat L, Dalrymple LS, Maddux FW Seminars in nephrology (2018)
[59]
Provision of renal care for patients with end stage kidney disease in persistent vegetative state, in United Arab Emirates: a national survey of renal physicians. — Alshamsi FE, Chaaban A, Alrukhaimi M, Bernieh B, Bakoush O The Libyan journal of medicine (2018)
[60]
Unmet Palliative Care Needs Among Patients With End-Stage Kidney Disease: A National Registry Study About the Last Week of Life. — Axelsson L, Alvariza A, Lindberg J, Öhlén J, Håkanson C, Reimertz H et al. Journal of pain and symptom management (2018)
[61]
Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium. — Laskin BL, Huang G, King E, Geary DF, Licht C, Metlay JP et al. Pediatric nephrology (Berlin, Germany) (2017)
[62]
Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease. — Kuo SZ, Haftek M, Lai JC Digestive diseases and sciences (2017)
[63]
Prescribing Non-Opioid Drugs in End-Stage Kidney Disease. — Wilcock A, Charlesworth S, Twycross R, Waddington A, Worthington O, Murtagh FEM et al. Journal of pain and symptom management (2017)
[64]
Understanding patterns and factors associated with place of death in patients with end-stage kidney disease: A retrospective cohort study. — Lovell N, Jones C, Baynes D, Dinning S, Vinen K, Murtagh FE Palliative medicine (2017)
[65]
Pediatric liver transplantation: a North American perspective. — Kerkar N, Lakhole A Expert review of gastroenterology & hepatology (2016)
[66]
Treatment of End-stage Kidney Failure without Renal Replacement Therapy. — Hole B, Tonkin-Crine S, Caskey FJ, Roderick P Seminars in dialysis (2016)
[67]
Intradialytic Exercise is Medicine for Hemodialysis Patients. — Parker K Current sports medicine reports (2016)
[68]
Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare. — Brown CL, Hammill BG, Qualls LG, Curtis LH, Muir AJ Journal of pain and symptom management (2016)
[69]
Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review. — Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi ST PloS one (2015)
[70]
Epistaxis in end stage liver disease masquerading as severe upper gastrointestinal hemorrhage. — Camus M, Jensen DM, Matthews JD, Ohning GV, Kovacs TO, Jutabha R et al. World journal of gastroenterology (2014)
[71]
Conservative care for end-stage kidney disease: joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine. — Alston H Clinical medicine (London, England) (2013)
[72]
If you can't comply with dialysis, how do you expect me to trust you with transplantation? Australian nephrologists' views on indigenous Australians' 'non-compliance' and their suitability for kidney transplantation. — Anderson K, Devitt J, Cunningham J, Preece C, Jardine M, Cass A International journal for equity in health (2012)
[73]
End-stage liver disease: challenges and practice implications. — Hansen L, Sasaki A, Zucker B The Nursing clinics of North America (2010)
[74]
Role and support for hepatologists at liver transplant programs in the United States. — Shiffman ML, Rockey DC Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2008)
[75]
A comparison of right and left lobectomies for living donor liver transplantation: an anesthesiologist's point of view. — Zeyneloglu P, Pirat A, Balci ST, Torgay A, Cinar O, Sevmis S et al. Transplantation proceedings (2008)
[76]
Vitamin D in health and disease. — Heaney RP Clinical journal of the American Society of Nephrology : CJASN (2008)
[77]
Multiple organ failure caused by end-stage liver disease successfully treated with living donor liver transplantation using perioperative percutaneous cardiopulmonary support: a case report. — Hayashi H, Shimizu K, Tani T, Takamura H, Takeshita M, Funaki K et al. Transplantation proceedings (2005)
[78]
Physician specialty and the outcomes and cost of admissions for end-stage liver disease. — Ko CW, Kelley K, Meyer KE The American journal of gastroenterology (2001)
[79]
The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. — Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA et al. The American journal of clinical nutrition (1992)

Share:Twitter Reddit LinkedIn